Advertisement

Topics

Mylan launches first follow-on glatiramer acetate in the UK

06:19 EST 15 Feb 2018 | Generics and Biosimilars Initiative

US generics giant Mylan announced on 23 January 2018 that it had launched Brabio, the first follow-on version of Teva Pharmaceutical’s (Teva) Copaxone (glatiramer acetate) in the UK.

Original Article: Mylan launches first follow-on glatiramer acetate in the UK

NEXT ARTICLE

More From BioPortfolio on "Mylan launches first follow-on glatiramer acetate in the UK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...